A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat neuropathic pain—increased the risk of hip fractures, especially in older patients who were frail or had kidney […]
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, were associated with fewer […]
In the wake of Donald Trump’s victory in the presidential election, retailers report that online sales of emergency contraceptives have soared. The spike in purchases of what is also known as the morning-after pill or […]
Over the past few decades, the opioid epidemic has gripped the United States, fueled in large part by the over-prescription of pain-relieving drugs like oxycodone. As those pharmaceuticals were made more difficult to obtain, opioids […]
Acupuncture. Ketamine infusions. “Electroshock” or electroconvulsive therapy. The existing treatment options for those diagnosed with major depressive disorder (MDD) and treatment-resistant depression (TRD), may sometimes feel daunting or expensive alternatives to medication. However, a groundbreaking […]
The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other targets to treat prostate cancer are still necessary […]
All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier in 2024, this drug is unlikely to be needed for those heart patients who […]
A multi-institutional study made up of 26 researchers led by the University of Melbourne has discovered that iron-reducing deferiprone accelerates cognitive decline in patients with early Alzheimer’s disease. This unexpected finding shows that reducing brain […]
The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says.This article was originally published on MedicalXpress.com
More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug Administration is proposing that it be removed from common over-the-counter decongestants.This […]
© 2024 SimplyWell.ca